Tags : Wharton Asset Management

Series A

Neurovalens secures £5 million Series A Follow On investment led

July 20, 2020 Health tech company Neurovalens raises more than £5 million to advance medical device approvals of its neurostimulation technology Northern Ireland founded scale-up business aims to treat conditions including diabetes, insomnia, anxiety and obesity Neurovalens, a global healthtech company headquartered in Belfast and San Diego, has raised £5.1 million in funding, which will be […]Read More

HealthTech

HealthTech company Neurovalens raises £4.6 million Series A investment led

Belfast-based health tech company, Neurovalens, has secured one of the largest ever Series A investments generated by a Northern Irish technology company. The company specialises in using neuroscience to solve everyday health issues. The £4.6 million raise was led by London-based Wharton Asset Management along with Cambridge based IQ Capital. The round was also supported […]Read More